Ligand Pharmaceuticals Incorporated (LGND)
NASDAQ: LGND · Real-Time Price · USD
232.15
+2.82 (1.23%)
May 26, 2026, 12:49 PM EDT - Market open
Ligand Pharmaceuticals Employees
Ligand Pharmaceuticals had 47 employees as of December 31, 2025. The number of employees decreased by 21 or -30.88% compared to the previous year.
Employees
47
Change (1Y)
-21
Growth (1Y)
-30.88%
Revenue / Employee
$5,839,915
Profits / Employee
$3,267,213
Market Cap
4.65B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 47 | -21 | -30.88% |
| Dec 31, 2024 | 68 | 10 | 17.24% |
| Dec 31, 2023 | 58 | -18 | -23.68% |
| Dec 31, 2022 | 76 | -78 | -50.65% |
| Dec 31, 2021 | 154 | -1 | -0.65% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Legend Biotech | 2,965 |
| Caris Life Sciences | 1,846 |
| Crinetics Pharmaceuticals | 594 |
| Travere Therapeutics | 497 |
| TG Therapeutics | 399 |
| CRISPR Therapeutics AG | 393 |
| Xenon Pharmaceuticals | 370 |
| NewAmsterdam Pharma Company | 100 |
LGND News
- 8 days ago - Ligand Pharmaceuticals Proxy statement: Proxy filing - Filings
- 17 days ago - Ligand Pharmaceuticals Q1 Earnings Call Highlights - MarketBeat
- 19 days ago - Ligand reports Q1 adjusted EPS $1.63, consensus $1.80 - TheFly
- 19 days ago - Ligand backs FY26 adjusted EPS view $8.50-$9.50, consensus $9.21 - TheFly
- 19 days ago - Ligand Pharmaceuticals Earnings Call Transcript: Q1 2026 - Transcripts
- 19 days ago - Ligand Pharmaceuticals Earnings release: Q1 2026 - Filings
- 19 days ago - Ligand Pharmaceuticals Slides: Q1 2026 - Filings
- 19 days ago - Ligand Pharmaceuticals Quarterly report: Q1 2026 - Filings